The Brightlands Maastricht Health Campus celebrates its tenth anniversary this week. The campus now houses more than 115 companies and institutes where over 11,000 professionals and also over 11,000 students work together on valuable innovations within healthcare, medicine and life sciences.
Recently, UM’s president Rianne Letschert wrote an opinion piece for TH&MA. The journal informs managers, directors and executives at universities and colleges of higher education in both Flanders and the Netherlands about the latest trends in higher education. You can read the opinion piece here. (in Dutch)
Piet Leroy appointed professor in 'Procedural Sedation and Analgesia (PROSA) in children' at Maastricht University.
Emeritus professor Marjolein Drent received the Sarcoidosis Crystal Award for Excellence in Research and Clinical Care. She receives this international award for her achievements in the field of research and counselling of sarcoidosis patients on 24 May. This year's award is presented for the first time by the Foundation for Sarcoidosis Research (FSR), an international organisation dedicated to raising awareness and improving care for sarcoidosis patients.
Once a refugee, she is now rector magnificus of Maastricht University. Both roles underline the importance of human rights and that’s why Pamela Habibović spoke at the opening of Maastricht Human Rights Week on 22 May.
The number of foreign students arriving at Dutch universities will not be restricted, at least for the time being. This is a good thing, according to ongoing research by Carla Haelermans from the School of Business and Economics (SBE) and Patrick Bijsmans from the Faculty of Arts and Social Sciences (FASoS). “Students, including Dutch ones, perform exceptionally well in tutorial groups with a mix of nationalities. And internationalisation is the future. You can’t put restrictions on that.”
Melissa Schepers' doctoral research at Maastricht University and Hasselt University offers hope for the development of a new medication that can halt or restore the limitations of multiple sclerosis (MS).
Operating cataracts in both eyes on the same day instead of with a two-week interval is equally safe but more cost-effective and patient-friendly.
